These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12553000

  • 1. p63 expression profile in normal and malignant prostate epithelial cells.
    Davis LD, Zhang W, Merseburger A, Young D, Xu L, Rhim JS, Moul JW, Srivastava S, Sesterhenn IA.
    Anticancer Res; 2002; 22(6C):3819-25. PubMed ID: 12553000
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH, Signoretti S, Loda M.
    Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
    [Abstract] [Full Text] [Related]

  • 3. p63 expression profiles in human normal and tumor tissues.
    Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C.
    Clin Cancer Res; 2002 Feb; 8(2):494-501. PubMed ID: 11839669
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
    Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM.
    Cancer Res; 2002 Apr 15; 62(8):2220-6. PubMed ID: 11956072
    [Abstract] [Full Text] [Related]

  • 6. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.
    Hum Pathol; 2007 Feb 15; 38(2):332-41. PubMed ID: 17134736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.
    Tran CP, Lin C, Yamashiro J, Reiter RE.
    Mol Cancer Res; 2002 Dec 15; 1(2):113-21. PubMed ID: 12496358
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.
    Koga F, Kawakami S, Fujii Y, Saito K, Ohtsuka Y, Iwai A, Ando N, Takizawa T, Kageyama Y, Kihara K.
    Clin Cancer Res; 2003 Nov 15; 9(15):5501-7. PubMed ID: 14654529
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
    Ali TZ, Epstein JI.
    Am J Surg Pathol; 2008 Dec 15; 32(12):1890-5. PubMed ID: 18813120
    [Abstract] [Full Text] [Related]

  • 15. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK, Hsue SS, Lin LM.
    J Oral Pathol Med; 2005 Apr 15; 34(4):232-9. PubMed ID: 15752259
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R, Tsybrovskyy O, Ratschek M, Rehak P, Lipsky K, Langner C.
    Urology; 2004 Jun 15; 63(6):1079-83. PubMed ID: 15183954
    [Abstract] [Full Text] [Related]

  • 17. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG, Gardner WA.
    Med Hypotheses; 2008 Jun 15; 70(2):387-408. PubMed ID: 17658698
    [Abstract] [Full Text] [Related]

  • 18. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Trevisiol L, Carinci F, Leonardi R, De Lillo A, Lanzafame S, Bufo P, Piattelli A.
    Hum Pathol; 2005 Feb 15; 36(2):187-94. PubMed ID: 15754296
    [Abstract] [Full Text] [Related]

  • 19. p63 and epithelial biology.
    Barbieri CE, Pietenpol JA.
    Exp Cell Res; 2006 Apr 01; 312(6):695-706. PubMed ID: 16406339
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
    Gu Y, Li H, Miki J, Kim KH, Furusato B, Sesterhenn IA, Chu WS, McLeod DG, Srivastava S, Ewing CM, Isaacs WB, Rhim JS.
    Exp Cell Res; 2006 Apr 01; 312(6):831-43. PubMed ID: 16413016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.